Results 181 to 190 of about 60,532 (324)

18FDG-PET: a new diagnostic approach in hip prosthesis infection [PDF]

open access: green, 2007
Elena Garcia-Barrecheguren   +4 more
openalex   +1 more source

Dual Growth Factor Release From Collagen Based Multilayer Films on Ti‐Surfaces Enhances Periimplant Bone Formation and Angiogenic Activity—An Experimental In‐Vivo Study

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of the present study was to assess the effect of dual growth factor release from collagen‐based polyelectrolyte multilayer films (PEMs) on titanium implants on periimplant bone formation and angiogenetic activity in minipig mandibles.
Philipp Kauffmann   +7 more
wiley   +1 more source

Medical countermeasures during public health emergencies—Does information sharing among health system coalition help?

open access: yesDecision Sciences, EarlyView.
Abstract Challenged by constrained healthcare resources, hospitals encounter barriers to accommodating patient demand during public health emergencies. Building on a comprehensive literature review of information and knowledge exchange in healthcare, disaster management, and humanitarian operations management, this study explores the influence of ...
Sukrit Pal, Anand Nair
wiley   +1 more source

Can we trust combined anteversion and Lewinnek safe zone to avoid hip prosthesis dislocation? [PDF]

open access: yesJ Clin Orthop Trauma, 2021
Hernández A   +5 more
europepmc   +1 more source

Maintenance of bone mineral density after implantation of a femoral neck hip prosthesis [PDF]

open access: gold, 2008
Ralf Decking   +4 more
openalex   +1 more source

Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Haemophilia A and B are hereditary bleeding disorders that require multidisciplinary perioperative management. Data on orthopaedic surgery outcomes with extended‐half‐life (EHL) recombinant Fc‐fusion factor VIII (rFVIIIFc) and factor IX (rFIXFc) products remain limited.
Luigi Piero Solimeno   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy